Creating new materials to treat eye and skin injuries from chemical exposure
Lipid Based Self Assembled Materials Synthesis and Characterization
This study is exploring new ways to help heal injuries from harmful chemicals, like those that can affect your skin and eyes, by creating tiny particles that can deliver treatments right where they're needed, making recovery easier for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10907604 on NIH RePORTER |
What this research studies
This research focuses on developing innovative lipid-based materials that can help heal injuries caused by harmful chemicals like nitrogen and sulfur mustards. By synthesizing nanoparticles that mimic high-density lipoproteins (HDLs), the team aims to create therapeutics that can effectively target and deliver treatments to specific cells in the eye and skin. The approach involves controlling the size and composition of these nanoparticles to enhance their effectiveness in modulating the immune response and repairing tissue damage. Patients may benefit from these novel therapies designed to improve recovery from chemical exposure.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have suffered eye or skin injuries due to exposure to nitrogen or sulfur mustards.
Not a fit: Patients with injuries not related to chemical exposure or those with other unrelated skin or eye conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advanced treatments that significantly improve healing and recovery for patients affected by chemical injuries.
How similar studies have performed: Previous research has shown promise in using lipid-based nanoparticles for therapeutic delivery, indicating potential success for this novel approach.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Thaxton, Colby Shad — Northwestern University at Chicago
- Study coordinator: Thaxton, Colby Shad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.